Vertero Therapeutics has completed patient enrollment in a Phase 1b clinical trial testing VT-5006, an experimental treatment designed…
Articles by Andrea Lobo
Women with Parkinson’s disease experience more severe motor complications and depression, while men are more likely to have cognitive…
Researchers at Mayo Clinic are testing whether low-dose radiation therapy can slow the progression of Parkinson’s disease by reducing…
XS411, Xellsmart’s experimental stem cell therapy, was generally well tolerated and associated with improved motor function in people with…
The first patient has been dosed in Mission Therapeutics’ Phase 1b clinical trial of MTX325, an oral treatment for…
Phase 1 trial results showed an experimental oral therapy was associated with improved eye movement control, lower levels of neuroinflammatory…
The 150 mg dose of solengepras (CVN424), Cerevance’s investigational oral treatment for Parkinson’s disease, significantly reduced average daily…
The first patient has been dosed in a Phase 2a clinical trial evaluating Jotrol, an investigational oral formulation of resveratrol…
Amprion and Prema Cognition have entered into a collaboration to explore an approach for identifying and evaluating people…
Blue light therapy delivered through Chrono Eyewear’s Propeaq glasses may help people with Parkinson’s disease sleep better and…